top of page
Search

Kemenkes Jelaskan Alasan Banyak Pasien Indonesia Masih Memilih Berobat ke Luar Negeri

Jakarta, detikHealth - Minggu (26/10) Kementerian Kesehatan (Kemenkes) RI mengungkap alasan mengapa masih banyak masyarakat Indonesia yang memilih berobat ke luar negeri, meskipun industri alat kesehatan (alkes) dalam negeri telah berkembang pesat.


ree

Menurut Direktur Jenderal Alat Kesehatan Kementrian Kesehatan RI, Ibu Lucia Rizka Andalusia, penyebab utamanya adalah terbatasnya akses terhadap teknologi kesehatan yang inovatif dan canggih di dalam negeri. Kondisi ini membuat banyak pasien lebih memilih berobat ke negara tetangga yang menawarkan layanan kesehatan modern dengan waktu tunggu yang lebih singkat dan efisiensi lebih baik.


Rizka menegaskan bahwa persoalan ini bukan sekadar masalah preferensi pasien, melainkan mencerminkan lambatnya adopsi teknologi kesehatan mutakhir di rumah sakit dalam negeri, yang berdampak pada kualitas dan kecepatan layanan.


Kemenkes, lanjutnya, terus berupaya memperkuat ekosistem teknologi kesehatan Indonesia melalui berbagai inisiatif seperti penerapan kebijakan Tingkat Komponen Dalam Negeri (TKDN), mekanisme freeze–unfreeze impor, serta program business matching yang mempertemukan produsen alkes lokal dengan rumah sakit.


Namun, Rizka mengakui bahwa akses terhadap teknologi inovatif masih menjadi tantangan terbesar bagi Indonesia. Tanpa percepatan dalam adopsi dan ketersediaannya, pasien akan terus mencari pengobatan ke luar negeri.


“Pemerintah berkomitmen agar masyarakat dapat mengakses teknologi kesehatan inovatif di dalam negeri, sehingga tidak perlu lagi berobat ke luar negeri,” tegasnya.


Oleh: Nafilah - Senin, 27/10/2025 08:46 WIB



[ENGLISH]


Ministry of Health Reveals Why Many Indonesians Still Seek Medical Treatment Abroad


Although Indonesia’s domestic medical device sector has made impressive strides, many Indonesians still choose to seek healthcare overseas, according to Lucia Rizka Andalusia, Director General of Medical Devices at the Ministry of Health (MOH). She explained that this ongoing trend is largely due to limited access to innovative medical technologies within the country.


“When people find it difficult to access advanced medical devices or treatments in Indonesia, it’s understandable that they opt to go abroad, where such technologies are more readily available,” Rizka stated during a press conference on October 26, 2025.

She noted that this issue is not simply a matter of patient preference but rather reflects the slow availability and adoption of advanced healthcare technologies in local hospitals, which in turn affects service delivery.


“For example, radiotherapy services in Indonesia often involve waiting times of several weeks or even months, whereas patients in neighboring countries can receive treatment much faster. This is one of the main reasons people decide to go abroad,” she added.


Nevertheless, Rizka emphasized that Indonesia’s medical device manufacturing industry has grown significantly. Before the COVID-19 pandemic, there were only around 400 companies, most of them dependent on imported components. Today, that number has doubled to approximately 815, showing substantial development and growing self-sufficiency.


To further support local production, the MOH has implemented key policies such as the Local Content Requirement (TKDN) and the freeze–unfreeze mechanism on imports.


“Once domestic manufacturers can supply sufficient quantities of a product, we freeze imports of similar items. This policy has proven effective, encouraging government and vertical hospitals to use locally made products,” Rizka explained.


The Ministry has also organized business matching programs to link local medical device manufacturers with healthcare facilities, ensuring better visibility and collaboration.


“Without business matching, many hospitals simply don’t know about local innovations. For instance, an Indonesian company might already be producing automated electric hospital beds, but hospitals keep buying imported ones because they’re unaware,” she said.


She also mentioned that partnerships with international companies like Linet and DV Medika, which plan to manufacture advanced hospital beds in Indonesia, are encouraged — as long as they comply with procurement guidelines and maintain competitive pricing and quality standards.


While the growth of Indonesia’s medical device industry is a positive achievement, Rizka highlighted that the country’s main challenge lies in improving access to innovative healthcare technologies.


“If this issue isn’t addressed, patients will continue traveling abroad for care,” she cautioned. “The government is working hard to make innovative medical technologies available faster, so Indonesians can receive the same quality of treatment at home.”


In conclusion, Indonesia’s rapidly expanding medical device sector shows strong potential for industrial independence, but gaps in access, service efficiency, and technology adoption remain key obstacles to keeping patients within the national healthcare system.


By: Nafilah - Monday, 27/10/2025 08:46 WIB


 
 
 
bottom of page